13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-12, with 41 holding rows worth $210,939,687.
- Accession
- 0001420506-23-001021
- Filer
- CIK 1617201
- Filed
- 2023-05-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2023
A holdings report, 41 entries on the cover page, a total value of $210,939,687 stated on the cover page (in dollars after the unit check, H1), rows summing to $210,939,687 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PROTHENA CORP PLC SHS | G72800108 | Stock | 447,092 | $21,670,549 | dollars as filed | |
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 375,500 | $14,509,320 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 567,826 | $13,639,181 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 24,000 | $11,651,040 | dollars as filed | |
| CENTENE CORP DEL COM | 15135B101 | Stock | 161,404 | $10,202,347 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 3,200,000 | $10,016,000 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 1,074,593 | $8,962,105 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 316,165 | $8,912,691 | dollars as filed | |
| HORIZON THERAPEUTICS PLC | G46188101 | SHS | 81,035 | $8,844,160 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,545,000 | $8,806,500 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 80,000 | $8,097,600 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 1,488,917 | $7,697,701 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 3,257,360 | $6,351,852 | dollars as filed | |
| ARCTURUS THERAPEUTICS HLDGS | 03969T109 | COM | 255,000 | $6,112,350 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 2,021,668 | $5,943,704 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 753,528 | $5,681,601 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 10,935 | $5,167,772 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 154,900 | $4,921,173 | dollars as filed | |
| QUIDELORTHO CORP COM | 219798105 | Stock | 48,355 | $4,307,947 | dollars as filed | |
| CUE BIOPHARMA INC | 22978P106 | COM | 1,151,855 | $4,112,122 | dollars as filed | |
| Johnson & Johnson | 478160104 | COM | 25,210 | $3,907,550 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 62,081 | $3,832,881 | dollars as filed | |
| ALDEYRA THERAPEUTICS INC | 01438T106 | COM | 383,447 | $3,807,629 | dollars as filed | |
| PACIRA BIOSCIENCES INC COM | 695127100 | Stock | 91,123 | $3,718,730 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 900,600 | $3,611,406 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,179,090 | $3,549,061 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 678,300 | $2,218,041 | dollars as filed | |
| GRAPHITE BIO INC | 38870X104 | COM | 876,666 | $2,147,832 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 240,000 | $1,886,400 | dollars as filed | |
| GALAPAGOS NV | 36315X901 | SPON ADR | 40,000 | $1,545,600 | dollars as filed | call |
| ModivCare Inc | 60783X104 | Common Stock | 15,452 | $1,299,204 | dollars as filed | |
| TELADOC HEALTH INC | 87918A105 | COM | 45,900 | $1,188,810 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L900 | CALL | 200,000 | $626,000 | dollars as filed | call |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 26,359 | $449,421 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 42,537 | $433,877 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 8,464 | $318,585 | dollars as filed | |
| ELUTIA INC | 05479K106 | CL A COM | 196,443 | $296,629 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 13,000 | $215,540 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 281,902 | $191,101 | dollars as filed | |
| LIFESTANCE HEALTH GROUP INC | 53228F101 | COM | 9,000 | $66,870 | dollars as filed | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 273 | $20,805 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-001021 | this filing | 2023-05-12 | acceptance time not in the bulk data set |